Skip to content
10-Q

Quarterly Report

ASSEMBLY BIOSCIENCES, INC. ASMB

0001193125-26-211987

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 15.89M sh
Shares Diluted Q1 2026 · Mar 31, 2026 16.9M sh
Shares Diluted Q1 2026 · Mar 31, 2025 7.51M sh
Capex Q1 2026 · Mar 31, 2026 $19K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$22.1M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$23.44M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $31.12M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $58.45M
Stockholders Equity Q1 2026 · Mar 31, 2026 $198.61M
Stockholders Equity Q1 2026 · Dec 31, 2025 $206.75M
Stockholders Equity Q1 2026 · Mar 31, 2025 $27.13M
Stockholders Equity Q1 2026 · Dec 31, 2024 $33.36M
Current Liabilities Q1 2026 · Mar 31, 2026 $35M
Current Liabilities Q1 2026 · Dec 31, 2025 $48.78M
Total Liabilities Q1 2026 · Mar 31, 2026 $36.9M
Total Liabilities Q1 2026 · Dec 31, 2025 $50.84M
Current Assets Q1 2026 · Mar 31, 2026 $232.61M
Current Assets Q1 2026 · Dec 31, 2025 $254.55M
Total Assets Q1 2026 · Mar 31, 2026 $235.51M
Total Assets Q1 2026 · Dec 31, 2025 $257.59M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.54
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.17
Eps Basic Q1 2026 · Mar 31, 2026 −$0.54
Eps Basic Q1 2026 · Mar 31, 2025 −$1.17
Sga Expense Q1 2026 · Mar 31, 2026 $4.68M
Sga Expense Q1 2026 · Mar 31, 2025 $4.51M
Rd Expense Q1 2026 · Mar 31, 2026 $14.9M
Rd Expense Q1 2026 · Mar 31, 2025 $14.85M
Net Income Q1 2026 · Mar 31, 2026 −$9.08M
Net Income Q1 2026 · Mar 31, 2025 −$8.82M
Operating Income Q1 2026 · Mar 31, 2026 −$11.37M
Operating Income Q1 2026 · Mar 31, 2025 −$9.94M